Buying Buzz: ChromaDex Corporation [CDXC] Cheif Executive Officer Fried Robert N purchases 80,000 shares of the company

0
10

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. ChromaDex Corporation shares valued at $100,000 were purchased by Fried Robert N on Sep 30. At $1.25 per share, Fried Robert N acquired 80,000 shares. The insider’s holdings grew to 972,314 shares worth approximately $1.65 million following the completion of this transaction.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored


Also, Chau Hoi Shuen Solina Holly purchased 960,000 shares, netting a total of over 1,200,000 in proceeds. Following the buying of shares at $1.25 each, the insider now holds 7,885,641 shares.

Before that, Chau Hoi Shuen Solina Holly had added 60,037 shares to its account. In a trade valued at $99,878, the 10% Owner bought ChromaDex Corporation shares for $1.66 each. Upon closing the transaction, the insider’s holdings increased to 60,037 shares, worth approximately $11.77 million.

As published in a research note from Oppenheimer on August 16, 2022, ChromaDex Corporation [CDXC] has been rated down from an Outperform to a Perform. Analysts at B. Riley Securities downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in mid August. As of March 08, 2022, ROTH Capital has initiated its “Buy” rating for CDXC. Earlier on October 16, 2019, Oppenheimer initiated its rating. Their recommendation was “an Outperform” for CDXC stock.

Analyzing CDXC Stock Performance

On Thursday, ChromaDex Corporation [NASDAQ: CDXC] rose 1.80% to $1.70. The stock’s lowest price that day was $1.58, but it reached a high of $1.84 in the same session. During the last five days, there has been a surge of approximately 9.68%. Over the course of the year, ChromaDex Corporation shares have dropped approximately -54.55%. Shares of the company reached a 52-week high of $4.0300 on 01/04/22 and a 52-week low of $1.1500 on 09/27/22. A 50-day SMA is recorded $1.4148, while a 200-day SMA reached $1.9445. Nevertheless, trading volume fell to 0.5 million shares from 0.18 million shares the previous day.

Support And Resistance Levels for ChromaDex Corporation (CDXC)

According to the 24-hour chart, there is a support level at 1.5733, which, if violated, would cause prices to drop to 1.4467. In the upper region, resistance lies at 1.8333. The next price resistance is at 1.9667. RSI (Relative Strength Index) is 66.71 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.1607, which suggests the price will decrease in the coming days. Percent R is at 25.00%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.

Is ChromaDex Corporation subject to short interest?

Stocks of ChromaDex Corporation saw a sharp steep in short interest on Jul 14, 2022 dropping by -1.46 million shares to 2.04 million. Data from Yahoo Finance shows that the short interest on Jun 14, 2022 was 3.5 million shares. A decline of -71.57% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.67 of the overall float, the days-to-cover ratio (short ratio) decline to 2.67.

Which companies own the most shares of ChromaDex Corporation (CDXC)?

According to Tieton Capital Management LLC filings, the company currently owns 2,285,015 shares, which is about 3.34% of the total CDXC shares outstanding. The investor’s shares have appreciated by 856,273 from its previous 13-F filing of 1428742.0 shares. With the completion of the sale transaction, The Vanguard Group, Inc.’s stake is now worth $2,661,136. Yong Rong reduced a -28.64% interest valued at $2.38 million while Iconiq Capital LLC 0 stake. In its current portfolio, Renaissance Technologies LLC holds 739,900 shares valued at $0.91 million.

In terms of ChromaDex Corporation share price expectations, FactSet research, analysts set an average price target of $5.87 in the next 12 months, up nearly 229.34% from the previous closing price of $1.67. Analysts anticipate ChromaDex Corporation stock to reach $10.00 by 2022, with the lowest price target being $2.10. In spite of this, 6 analysts ranked ChromaDex Corporation stock as an Overweight at the end of 2022. On February 14, 2019, B. Riley FBR assigned a price target of “a Buy” to the stock and initiated coverage with a $7.

LEAVE A REPLY

Please enter your comment!
Please enter your name here